Tuesday, 13 June 2017
A new anti-diabetic drug, known for reducing blood sugar levels in people with type-2 diabetes, proved to be successful in reducing the risk of cardiovascular disease, according to a recent study published in the New England Journal of Medicine in the Unites States. Conducted in 30 countries and on more than 10,000 patients, the clinical experiment showed that the oral drug, known as Invokana (canagliflozin), reduced the risk of hospitalization due to heart failure for those affected by diabetes ...
Sunday, 22 May 2016
Alaa Shafie and his wife Amal Ashour are part of the team at the University of Warwick, United Kingdom, who made the breakthrough